Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu

Clin Mol Hepatol. 2024;30(2):293-296. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0101

View: 645 Download: 28

Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho

Clin Mol Hepatol. 2022;28(1):17-30. Published online July 20, 2021

DOI: https://doi.org/10.3350/cmh.2021.0093

View: 9458 Download: 626 Web of Science: 25 Crossref: 27

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 8463 Download: 80 Web of Science: 3 Crossref: 3

Seong Gyu Hwang

Clin Mol Hepatol. 2005;11(4):311-319. Published online January 1, 1970

View: 2324 Download: 14

Yun Soo Kim

Clin Mol Hepatol. 2005;11(1):9-12. Published online January 1, 2000

View: 2386 Download: 17

1 |

Viewed By 5456	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5434	MAFLD: How is it different from NAFLD?
Viewed By 5320	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3982	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3979	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search